LSBMergers•prnewswire•
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
Sentiment:Negative (30)
Summary
BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by prnewswire